Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.92 EUR | -0.64% |
|
+0.26% | -7.90% |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| 09/05 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 298.2Cr 342.01Cr 276.18Cr 258.54Cr 484.88Cr 32TCr 487.81Cr 3.28TCr 1.27TCr 16TCr 1.28TCr 1.26TCr 55TCr | P/E 2026 * |
22.3x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 295.95Cr 339.43Cr 274.1Cr 256.59Cr 481.22Cr 32TCr 484.13Cr 3.25TCr 1.26TCr 16TCr 1.27TCr 1.25TCr 55TCr | EV / Sales 2026 * |
3.82x | EV / Sales 2027 * | 3.17x |
| Free-Float |
31.63% | Yield 2026 * |
1.67% | Yield 2027 * | 2.01% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.64% | ||
| 1 week | +0.26% | ||
| Current month | -2.10% | ||
| 1 month | -0.26% | ||
| 3 months | -27.44% | ||
| 6 months | -5.36% | ||
| Current year | -7.90% |
| 1 week | 58.1 |  | 59.3 |
| 1 month | 57.4 | | 61 |
| Current year | 57.4 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 38.38 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +0.26% | - | - | 342.25Cr | |
| +32.62% | -5.37% | +39.94% | +145.38% | 98TCr | |
| -3.20% | -4.17% | +51.52% | +39.07% | 55TCr | |
| -2.14% | -3.68% | +16.71% | +56.15% | 38TCr | |
| -1.75% | +0.25% | +25.86% | +16.53% | 32TCr | |
| +0.61% | -1.69% | +25.42% | +13.64% | 27TCr | |
| +0.22% | -3.10% | +24.25% | +30.21% | 27TCr | |
| +4.59% | +1.98% | -40.02% | -45.89% | 19TCr | |
| -1.90% | -4.65% | +16.56% | +47.00% | 18TCr | |
| -1.35% | -1.68% | +14.59% | +56.94% | 15TCr | |
| Average | -0.51% | -2.68% | +19.43% | +39.89% | 36.6TCr | |
| Weighted average by Cap. | -0.97% | -3.38% | +28.25% | +64.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 89Cr 72Cr 67Cr 125.86Cr 8.38TCr 126.62Cr 850.44Cr 329.59Cr 4.12TCr 333.23Cr 326.09Cr 14TCr | 91Cr 104.73Cr 85Cr 79Cr 148.47Cr 9.88TCr 149.37Cr 1TCr 388.82Cr 4.86TCr 393.11Cr 384.68Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 12Cr 22Cr 1.44TCr 22Cr 146.11Cr 57Cr 708.37Cr 57Cr 56Cr 2.46TCr | 18Cr 21Cr 17Cr 16Cr 30Cr 1.98TCr 30Cr 200.61Cr 78Cr 972.57Cr 79Cr 77Cr 3.38TCr |
| Net Debt | -2.25Cr -2.58Cr -2.09Cr -1.95Cr -3.66Cr -243.85Cr -3.69Cr -25Cr -9.59Cr -120.03Cr -9.7Cr -9.49Cr -416.77Cr | -9.05Cr -10Cr -8.38Cr -7.85Cr -15Cr -979.65Cr -15Cr -99Cr -39Cr -482.2Cr -39Cr -38Cr -1.67TCr |
| Date | Price | Change |
|---|---|---|
| 18/26/18 | 58.30 € | -0.77% |
| 17/26/17 | 58.75 € | +0.60% |
| 16/26/16 | 58.40 € | -0.17% |
| 15/26/15 | 58.50 € | -0.09% |
| 12/26/12 | 58.55 € | +0.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
